AU Patent

AU2015230711A1 — Methods for iontophoretically treating nausea and migraine

Assigned to Teva Pharmaceuticals International GmbH · Expires 2015-10-08 · 11y expired

What this patent protects

Abstract Methods for treating nausea and migraine by iontophoretically administering triptan compounds are provided.

USPTO Abstract

Abstract Methods for treating nausea and migraine by iontophoretically administering triptan compounds are provided.

Drugs covered by this patent

sumatriptan-succinate (SUMATRIPTAN SUCCINATE)

Patent Metadata

Patent number: AU2015230711A1
Jurisdiction: AU
Classification: —
Expires: 2015-10-08
Drug substance claim: No
Drug product claim: No
Assignee: Teva Pharmaceuticals International GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.